Protein Flexibility in Ligand Docking and Virtual Screening to Protein Kinases

Journal of Molecular Biology

Volumn 337, Issue 1, 2004, Pages 209-225

  Cavasotto, Claudio N ^a   Abagyan, Ruben A ^a  

^a MOLSOFT LLC   (United States)

Author keywords

Ligand docking; Protein flexibility and induced fit; Protein kinases; Structure based drug design; Virtual screening

Indexed keywords

PROTEIN KINASE;

ALGORITHM; ARTICLE; CALCULATION; CONFORMATIONAL TRANSITION; CRYSTAL STRUCTURE; LIGAND BINDING; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CROSS LINKING; PROTEIN FAMILY; PROTEIN FOLDING; PROTEIN STABILITY; SCREENING TEST;

EID: 1442351132     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2004.01.003     Document Type: Article

References (55)

1. Amzel L.M. Structure-based drug design. Curr. Opin. Biotechnol. 9:1998;366-369.
2. Rosenfeld R., Vajda S., DeLisi C. Flexible docking and design. Annu. Rev. Biophys. Biomol. Struct. 24:1995;677-700.
3. Taylor R.D., Jewsbury P.J., Essex J.W. A review of protein-small molecule docking methods. J. Comput. Aided Mol. Des. 16:2002;151-166.
4. Abagyan R., Totrov M. High-throughput docking for lead generation. Curr. Opin. Chem. Biol. 5:2001;375-382.
5. Shoichet B.K., McGovern S.L., Wei B., Irwin J.J. Lead discovery using molecular docking. Curr. Opin. Chem. Biol. 6:2002;439-446.
6. Murray C.W., Baxter C.A., Frenkel A.D. The sensitivity of the results of molecular docking to induced fit effects: application to thrombin, thermolysin and neuraminidase. J. Comput. Aided Mol. Des. 13:1999;547-562.
7. Davis A.M., Teague S.J. Hydrogen bonding, hydrophobic interactions, and failure of the rigid receptor hypothesis. Angew. Chem. Int. Ed. Engl. 38:1999;736-749.
8. Teague S.J. Implications of protein flexibility for drug discovery. Nature Rev. Drug Discov. 2:2003;527-541.
9. Bouzida D., Rejto P.A., Arthurs S., Colson A.B., Freer S.T., Gehlhaar D.K., et al. Computer simulations of ligand-protein binding with ensembles of protein conformations: a Monte Carlo study of HIV-1 protease binding energy landscapes. Int. J. Quantum Chem. 72:1999;73-84.
10. Cheney D., Mueller L. Evaluation of strategies for molecular docking. Abstr. Pap. Am. Chem. Soc. 226:2003;144.
11. Jiang F., Kim S.H. Soft docking: matching of molecular surface cubes. J. Mol. Biol. 219:1991;79-102.
12. Leach A.R. Ligand docking to proteins with discrete side-chain flexibility. J. Mol. Biol. 235:1994;345-356.
13. Jones G., Willett P., Glen R.C. Molecular recognition of receptor sites using a genetic algorithm with a description of desolvation. J. Mol. Biol. 245:1995;43-53.
14. Abagyan R., Totrov M., Kuznetsov D. ICM - a new method for protein modeling and design - applications to docking and structure prediction from the distorted native conformation. J. Comput. Chem. 15:1994;488-506.
15. Desmet J., Wilson I.A., Joniau M., De Maeyer M., Lasters I. Computation of the binding of fully flexible peptides to proteins with flexible side-chains. FASEB J. 11:1997;164-172.
16. Schaffer L., Verkhivker G.M. Predicting structural effects in HIV-1 protease mutant complexes with flexible ligand docking and protein side-chain optimization. Proteins: Struct. Funct. Genet. 33:1998;295-310.
17. Sandak B., Nussinov R., Wolfson H.J. A method for biomolecular structural recognition and docking allowing conformational flexibility. J. Comput. Biol. 5:1998;631-654.
18. Sandak B., Wolfson H.J., Nussinov R. Flexible docking allowing induced fit in proteins: insights from an open to closed conformational isomers. Proteins: Struct. Funct. Genet. 32:1998;159-174.
19. Carlson H.A. Protein flexibility is an important component of structure-based drug discovery. Curr. Pharm. Des. 8:2002;1571-1578.
20. Knegtel R.M., Kuntz I.D., Oshiro C.M. Molecular docking to ensembles of protein structures. J. Mol. Biol. 266:1997;424-440.
21. Claussen H., Buning C., Rarey M., Lengauer T. FlexE: efficient molecular docking considering protein structure variations. J. Mol. Biol. 308:2001;377-395.
22. Österberg F., Morris G.M., Sanner M.F., Olson A.J., Goodsell D.S. Automated docking to multiple target structures: incorporation of protein mobility and structural water heterogeneity in AutoDock. Proteins: Struct. Funct. Genet. 46:2002;34-40.
23. Morris G.M., Goodsell D.S., Huey R., Olson A.J. Distributed automated docking of flexible ligands to proteins: parallel applications of AutoDock 2.4. J. Comput. Aided Mol. Des. 10:1996;293-304.
24. Goodsell D.S., Morris G.M., Olson A.J. Automated docking of flexible ligands: applications of AutoDock. J. Mol. Recogn. 9:1996;1-5.
25. Morris G.M., Goodsell D.S., Halliday R.S., Huey R., Hart W.E., Belew R.K., Olson A.J. Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function. J. Comput. Chem. 19:1998;1639-1662.
26. Frimurer T.M., Peters G.H., Iversen L.F., Andersen H.S., Moller N.P., Olsen O.H. Ligand-induced conformational changes: improved predictions of ligand binding conformations and affinities. Biophys. J. 84:2003;2273-2281.
27. Schnecke V., Kuhn L.A. Virtual screening with solvation and ligand-induced complementarity. Persp. Drug Discov. Des. 20:2000;171-190.
28. Broughton H.B. A method for including protein flexibility in protein-ligand docking: improving tools for database mining and virtual screening. J. Mol. Graph. Model. 18:2000;247-257.
29. Carlson H.A., Masukawa K.M., Rubins K., Bushman F.D., Jorgensen W.L., Lins R.D., et al. Developing a dynamic pharmacophore model for HIV-1 integrase. J. Med. Chem. 43:2000;2100-2114.
30. Lin J.H., Perryman A.L., Schames J.R., McCammon J.A. Computational drug design accommodating receptor flexibility: the relaxed complex scheme. J. Am. Chem. Soc. 124:2002;5632-5633.
31. Lin J.H., Perryman A.L., Schames J.R., McCammon J.A. The relaxed complex method: accommodating receptor flexibility for drug design with an improved scoring scheme. Biopolymers. 68:2003;47-62.
32. Cavasotto C.N., Orry A.J.W., Abagyan R. Structure-based identification of binding sites, native ligands and potential inhibitors for G-protein coupled receptors. Proteins: Struct. Funct. Genet. 51:2003;423-433.
33. Taylor R.D., Jewsbury P.J., Essex J.W. FDS: flexible ligand and receptor docking with a continuum solvent model and soft-core energy function. J. Comput. Chem. 24:2003;1637-1656.
34. Dancey J., Sausville E.A. Issues and progress with protein kinase inhibitors for cancer treatment. Nature Rev. Drug Discov. 2:2003;296-313.
35. Totrov M., Abagyan R. Derivation of sensitive discrimination potential for virtual screening. RECOMB '99. Proceedings of the Third Annual International Conference on Computational Molecular Biology, Lyon, France. 1999;ACM Press, New York.
36. Totrov M., Abagyan R. Protein-ligand docking as an energy optimization problem. Raffa R.B. Drug-Receptor Thermodynamics: Introduction and Experimental Applications. 2001;603-624 Wiley, New York.
37. ICM Manual 3.0. 2003;Molsoft LLC, La Jolla, CA.
38. Schapira M., Abagyan R., Totrov M. Nuclear hormone receptor targeted virtual screening. J. Med. Chem. 46:2003;3045-3059.
39. Totrov M., Abagyan R. The contour-buildup algorithm to calculate the analytical molecular surface. J. Struct. Biol. 116:1996;138-143.
40. Abagyan R., Argos P. Optimal protocol and trajectory visualization for conformational searches of peptides and proteins. J. Mol. Biol. 225:1992;519-532.
41. Luque I., Freire E. Structural stability of binding sites: consequences for binding affinity and allosteric effects. Proteins: Struct. Funct. Genet. Suppl. 4:2000;63-71.
42. Fitzgerald C.E., Patel S.B., Becker J.W., Cameron P.M., Zaller D., Pikounis V.B., et al. Structural basis for p38α MAP kinase quinazolinone and pyridol-pyrimidine inhibitor specificity. Nature Struct. Biol. 10:2003;764-769.
43. Bernstein F.C., Koetzle T.F., Williams G.J., Meyer E.F. Jr, Brice M.D., Rodgers J.R., et al. The Protein Data Bank: a computer-based archival file for macromolecular structures. J. Mol. Biol. 112:1977;535-542.
44. Toledo L.M., Lydon N.B. Structures of staurosporine bound to CDK2 and cAPK - new tools for structure-based design of protein kinase inhibitors. Structure. 5:1997;1551-1556.
45. Engh R.A., Girod A., Kinzel V., Huber R., Bossemeyer D. Crystal structures of catalytic subunit of cAMP-dependent protein kinase in complex with isoquinolinesulfonyl protein kinase inhibitors H7, H8, and H89. Structural implications for selectivity. J. Biol. Chem. 271:1996;26157-26164.
46. Meijer L., Thunnissen A.M., White A.W., Garnier M., Nikolic M., Tsai L.H., et al. Inhibition of cyclin-dependent kinases, GSK-3beta and CK1 by hymenialdisine, a marine sponge constituent. Chem. Biol. 7:2000;51-63.
47. Dreyer M.K., Borcherding D.R., Dumont J.A., Peet N.P., Tsay J.T., Wright P.S., et al. Crystal structure of human cyclin-dependent kinase 2 in complex with the adenine-derived inhibitor H717. J. Med. Chem. 44:2001;524-530.
48. Stelmach J.E., Liu L., Patel S.B., Pivnichny J.V., Scapin G., Singh S., et al. Design and synthesis of potent, orally bioavailable dihydroquinazolinone inhibitors of p38 MAP kinase. Bioorg. Med. Chem. Letters. 13:2003;277-280.
49. Halgren T. Merck molecular force field I-V. J. Comput. Chem. 17:1995;490-641.
50. Abagyan R., Totrov M. Biased probability Monte-Carlo conformational searches and electrostatic calculations for peptides and proteins. J. Mol. Biol. 235:1994;983-1002.
51. Nemethy G., Gibson K.D., Palmer K.A., Yoon C.N., Paterlini M.G., Zagari A., et al. Energy parameters in polypeptides. 10. Improved geometrical parameters and nonbonded interactions for use in the ECEPP/3 algorithm, with application to proline-containing peptides. J. Phys. Chem. 96:1992;6472-6484.
52. Abagyan R.A., Totrov M. Ab initio folding of peptides by the optimal-bias Monte Carlo minimization procedure. J. Comput. Phys. 151:1999;402-421.
53. Metropolis N., Rosenbluth A.W., Rosenbluth M.N., Teller A.H., Teller E. Equation of state calculations by fast computing machines. J. Chem. Phys. 21:1953;1087-1092.
54. Totrov M., Abagyan R. Rapid boundary element solvation electrostatics calculations in folding simulations: successful folding of a 23-residue peptide. Biopolymers. 60:2001;124-133.
55. Wesson L., Eisenberg D. Atomic solvation parameters applied to molecular dynamics of proteins in solution. Protein Sci. 1:1992;227-235.